Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea
- 15 February 2013
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (8) , 1333-1337
Abstract
Background Several sickle cell clinical trials have closed due to inability to enroll patients. To limit the early cessation of a proposed clinical trial due to low accrual rates, we sought to better understand barriers and facilitators to enrolling parents of children with sickle cell anemia (SCD) into clinical trials. Procedure Focus groups (n = 3) were conducted with parents/guardians (n = 14) who had not previously been recruited for a clinical trial and were not administering hydroxyurea to their children. Results Three main themes related to barriers to clinical trial enrollment were identified during analysis of focus groups: general barriers to health related research (general mistrust of research studies, emotional and practical concerns), barriers to trial design (randomization), and barriers to hydroxyurea (long term unknown risks, cancer, myelosuppressive effects). Facilitators identified were need for more education, including request for peer education, and improved explanation of clinical trials or study rationale. Conclusion Engagement of parents/guardians of children with SCD in identifying barriers and facilitators to clinical trial enrollment may be critical to the development of strategies to enhance SCD trial completion. Pediatr Blood Cancer 2013;60:1333–1337.Keywords
This publication has 17 references indexed in Scilit:
- Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressureBlood, 2012
- Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)British Journal of Haematology, 2012
- Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trialContemporary Clinical Trials, 2012
- The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical CenterAcademic Medicine, 2011
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- Development of a Theory-Based (PEN-3 and Health Belief Model), Culturally Relevant Intervention on Cervical Cancer Prevention Among Latina Immigrants Using Intervention MappingHealth Promotion Practice, 2011
- Recruitment of infants with sickle cell anemia to a Phase III trial: Data from the BABY HUG studyContemporary Clinical Trials, 2010
- Race, Medical Researcher Distrust, Perceived Harm, and Willingness to Participate in Cardiovascular Prevention TrialsMedicine, 2008
- Barriers to the participation of African‐American patients with cancer in clinical trialsCancer, 2003
- Discontinuing penicillin prophylaxis in children with sickle cell anemiaThe Journal of Pediatrics, 1995